{ "cik": 1652130, "cik_padded": "0001652130", "entityName": "Intellia Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001193125-26-076550", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1129000.0, "cash": 155464000.0, "eps_diluted": -3.81, "free_cash_flow": -395865000.0, "net_income": -412694000.0, "operating_cash_flow": -394736000.0, "operating_income": -440990000.0, "revenue": 67671000.0, "stockholders_equity": 671394000.0, "total_assets": 842127000.0, "total_liabilities": 170733000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.25429628504276175, "revenue_growth_yoy": 0.16922093404979527, "roa_avg2y": -0.40596672539350426, "roa_period_end": -0.4900614752881691, "roe_avg2y": -0.5348028638999579, "roe_period_end": -0.6146822878965257 } }, { "accn": "0001193125-26-076550", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5778000.0, "cash": 189182000.0, "eps_diluted": -5.25, "free_cash_flow": -354658000.0, "net_income": -519021000.0, "operating_cash_flow": -348880000.0, "operating_income": -534263000.0, "revenue": 57877000.0, "stockholders_equity": 871956000.0, "total_assets": 1191015000.0, "total_liabilities": 319059000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3659118120639115, "revenue_growth_yoy": 0.5955065472088215, "roa_avg2y": -0.41655109647221983, "roa_period_end": -0.4357804057883402, "roe_avg2y": -0.5400491643363465, "roe_period_end": -0.5952376037322984 } }, { "accn": "0001193125-26-076550", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13985000.0, "cash": 226748000.0, "eps_diluted": -5.42, "free_cash_flow": -408071000.0, "net_income": -481192000.0, "operating_cash_flow": -394086000.0, "operating_income": -515291000.0, "revenue": 36275000.0, "stockholders_equity": 1050169000.0, "total_assets": 1300977000.0, "total_liabilities": 250808000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.23882632223956335, "revenue_growth_yoy": -0.30402333032750717, "roa_avg2y": -0.341138942345355, "roa_period_end": -0.36986972098661236, "roe_avg2y": -0.42103586870497384, "roe_period_end": -0.45820434615761846 } }, { "accn": "0001193125-26-076550", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13558000.0, "cash": 523506000.0, "eps_diluted": -6.16, "free_cash_flow": -346845000.0, "net_income": -474186000.0, "operating_cash_flow": -333287000.0, "operating_income": -458164000.0, "revenue": 52121000.0, "stockholders_equity": 1235584000.0, "total_assets": 1520114000.0, "total_liabilities": 284530000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2302797705376567, "revenue_growth_yoy": 0.5768916588509364, "roa_avg2y": -0.3369499797127669, "roa_period_end": -0.31194107810335275, "roe_avg2y": -0.4167151471903852, "roe_period_end": -0.3837747979902621 } }, { "accn": "0000950170-25-029007", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 12756000.0, "cash": 123406000.0, "eps_diluted": -3.78, "free_cash_flow": -237786000.0, "net_income": -267892000.0, "operating_cash_flow": -225030000.0, "operating_income": -267850000.0, "revenue": 33053000.0, "stockholders_equity": 1040244000.0, "total_assets": 1294464000.0 }, "period_end": "2021-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.4300617305238473, "roa_avg2y": -0.27186310436546635, "roa_period_end": -0.20695206664689014, "roe_avg2y": -0.34184810210576555, "roe_period_end": -0.2575280414979563 } }, { "accn": "0000950170-24-018736", "filed": "2024-02-22", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 3585000.0, "cash": 160020000.0, "eps_diluted": -2.4, "free_cash_flow": -53497000.0, "net_income": -134231000.0, "operating_cash_flow": -49912000.0, "operating_income": -136583000.0, "revenue": 57994000.0, "stockholders_equity": 527072000.0, "total_assets": 676322000.0 }, "period_end": "2020-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": 0.34547479293784655, "roa_avg2y": -0.2656456250828714, "roa_period_end": -0.19847202959537025, "roe_avg2y": -0.3368605174960129, "roe_period_end": -0.25467298585392506 } }, { "accn": "0000950170-23-004097", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 6794000.0, "cash": 57226000.0, "free_cash_flow": -110034000.0, "net_income": -474186000.0, "operating_cash_flow": -103240000.0, "operating_income": -106368000.0, "revenue": 43103000.0, "stockholders_equity": 269881000.0, "total_assets": 334280000.0 }, "period_end": "2019-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": 0.4162778471446409, "roa_avg2y": -1.3914010519443365, "roa_period_end": -1.4185293765705396, "roe_avg2y": -1.731234517644181, "roe_period_end": -1.757018834226937 } }, { "accn": "0001564590-21-009011", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 6358000.0, "cash": 58856000.0, "free_cash_flow": -67615000.0, "net_income": -85343000.0, "operating_cash_flow": -61257000.0, "operating_income": -90870000.0, "revenue": 30434000.0, "stockholders_equity": 277920000.0, "total_assets": 347315000.0 }, "period_end": "2018-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": 0.16529463567791094, "roa_avg2y": -0.23590076705134408, "roa_period_end": -0.24572218303269366, "roe_avg2y": -0.2950405951769784, "roe_period_end": -0.3070775762809442 } }, { "accn": "0001564590-21-009011", "filed": "2021-02-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 10091000.0, "cash": 340678000.0, "free_cash_flow": -75367000.0, "net_income": -67543000.0, "operating_cash_flow": -65276000.0, "operating_income": -69555000.0, "revenue": 26117000.0, "stockholders_equity": 300597000.0, "total_assets": 376235000.0 }, "period_end": "2017-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": 0.5848655865040354, "roa_avg2y": -0.20006694273138192, "roa_period_end": -0.17952343615027838, "roe_avg2y": -0.26464929844015095, "roe_period_end": -0.2246961879193738 } }, { "accn": "0001564590-20-007409", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 6165000.0, "cash": 273064000.0, "free_cash_flow": 29944000.0, "net_income": -31634000.0, "operating_cash_flow": 36109000.0, "operating_income": -32159000.0, "revenue": 16479000.0, "stockholders_equity": 209837000.0, "total_assets": 298969000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_period_end": -0.10581030140248654, "roe_period_end": -0.15075510991865115 } } ], "latest_filing": { "accn": "0001193125-26-076550", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2835", "sic_description": "In Vitro & In Vivo Diagnostic Substances", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001652130.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001652130.json" }, "ticker": "NTLA" }